Medicare Enrolled
Dr. Kamal Mandalapu, M.D.
Hematology & Oncology · Austell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mandalapu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mandalapu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mandalapu
Dr. Kamal Mandalapu is a hematology & oncology specialist in Austell, GA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Mandalapu performed 407 Medicare services across 273 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mandalapu received a total of $23,970 from 71 pharmaceutical and/or device companies across 595 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mandalapu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ 407 Medicare services
$23,970 industry payments
Medicare Practice Summary
Medicare Utilization ↗407
Medicare services
Bottom 33% in GA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
273
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~24 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
140 | $71 | $283 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
110 | $110 | $386 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
57 | $96 | $267 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
44 | $136 | $457 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $41 | $194 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $105 | $340 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$23,970
Total received (2018-2024)
Avg $3,424/year across 7 years
Top 16% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
595
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,258 (55.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,138 (42.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$575 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$10,005
2023
$8,112
2022
$1,480
2021
$825
2020
$779
2019
$1,516
2018
$1,253
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$5,798
BeiGene USA, Inc.
$694
PFIZER INC.
$535
Novartis Pharmaceuticals Corporation
$345
ABBVIE INC.
$277
Merck Sharp & Dohme LLC
$243
Genentech USA, Inc.
$178
Incyte Corporation
$153
Daiichi Sankyo Inc.
$143
Astellas Pharma US Inc
$137
Gilead Sciences, Inc.
$132
E.R. Squibb & Sons, L.L.C.
$120
Janssen Biotech, Inc.
$113
Eisai Inc.
$109
TerSera Therapeutics LLC
$94
SOBI, INC
$86
Exelixis Inc.
$84
Regeneron Healthcare Solutions, Inc.
$72
GlaxoSmithKline, LLC.
$62
Rigel Pharmaceuticals, Inc.
$58
ARRAY BIOPHARMA INC
$55
Lilly USA, LLC
$45
GENZYME CORPORATION
$45
Genmab U.S., Inc.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$31
JAZZ PHARMACEUTICALS INC.
$31
Acrotech Biopharma Inc.
$28
Aveo Pharmaceuticals, Inc.
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Blueprint Medicines Corporation
$25
Ipsen Biopharmaceuticals, Inc
$23
PUMA BIOTECHNOLOGY, INC.
$23
PharmaEssentia USA Corporation
$22
Karyopharm Therapeutics Inc.
$20
EMD Serono, Inc.
$20
ADC Therapeutics America, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$19
Agios Pharmaceuticals, Inc.
$17
Deciphera Pharmaceuticals Inc.
$17
SERVIER PHARMACEUTICALS LLC
$17
Mirati Therapeutics, Inc.
$14
Stemline Therapeutics Inc.
$14
Top 3 companies account for 70.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$6,897
Genentech USA, Inc.
$6,169
BeiGene USA, Inc.
$1,219
Novartis Pharmaceuticals Corporation
$754
PFIZER INC.
$713
E.R. Squibb & Sons, L.L.C.
$616
Seagen Inc.
$612
Daiichi Sankyo Inc.
$558
Merck Sharp & Dohme LLC
$462
Janssen Biotech, Inc.
$378
Incyte Corporation
$343
ABBVIE INC.
$326
Amgen Inc.
$321
Celgene Corporation
$271
Merck Sharp & Dohme Corporation
$261
GlaxoSmithKline, LLC.
$250
GENZYME CORPORATION
$235
Eisai Inc.
$225
Astellas Pharma US Inc
$224
Gilead Sciences, Inc.
$205
Bayer HealthCare Pharmaceuticals Inc.
$196
Boehringer Ingelheim Pharmaceuticals, Inc.
$172
TESARO, Inc.
$168
Pharmacyclics LLC, An AbbVie Company
$161
Rigel Pharmaceuticals, Inc.
$150
Regeneron Healthcare Solutions, Inc.
$145
TerSera Therapeutics LLC
$145
Seattle Genetics, Inc.
$139
Exelixis Inc.
$133
Lilly USA, LLC
$127
SOBI, INC
$86
JAZZ PHARMACEUTICALS INC.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$74
ARRAY BIOPHARMA INC
$69
Karyopharm Therapeutics Inc.
$58
MorphoSys, US Inc.
$55
G1 Therapeutics, Inc.
$55
Bayer Healthcare Pharmaceuticals Inc.
$52
EMD Serono, Inc.
$52
Stemline Therapeutics Inc.
$50
Pharmacyclics LLC, an AbbVie Company
$44
Pfizer Inc.
$40
Ipsen Biopharmaceuticals, Inc
$39
Genmab U.S., Inc.
$38
PUMA BIOTECHNOLOGY, INC.
$37
Alexion Pharmaceuticals, Inc.
$35
Deciphera Pharmaceuticals Inc.
$32
AMAG Pharmaceuticals, Inc.
$31
Mirati Therapeutics, Inc.
$31
Taiho Oncology, Inc.
$30
Acrotech Biopharma Inc.
$28
Aveo Pharmaceuticals, Inc.
$26
Jazz Pharmaceuticals Inc.
$25
Blueprint Medicines Corporation
$25
CTI BioPharma Corp.
$24
PharmaEssentia USA Corporation
$22
TOLMAR Pharmaceuticals, Inc.
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$19
ADC Therapeutics America, Inc.
$19
Janssen Pharmaceuticals, Inc
$19
Partner Therapeutics, Inc.
$19
AbbVie, Inc.
$18
EUSA Pharma (US) LLC
$18
Coherus Biosciences Inc.
$17
Epizyme, Inc.,
$17
Agios Pharmaceuticals, Inc.
$17
SERVIER PHARMACEUTICALS LLC
$17
Array BioPharma Inc.
$16
Puma Biotechnology, Inc.
$16
Verastem, Inc.
$14
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 59.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Abraxane · Alecensa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMEND · EMPLICITI · ENHERTU · EPKINLY · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · Fabhalta · GAZYVA · GILOTRIF · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · Lunsumio · MONJUVI · MVASI · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SUTENT · SYNAGIS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
149
Per 100K population
19.4
County median income
$98,712
Nearest hospital
WELLSTAR COBB MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mandalapu is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 16% of GA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mandalapu experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mandalapu performed 140 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mandalapu receive payments from pharmaceutical companies?
Yes. Dr. Mandalapu received a total of $23,970 from 71 companies across 595 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mandalapu's costs compare to other hematology & oncology specialists in Austell?
Dr. Mandalapu's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mandalapu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Austell
Browse hematology & oncology specialists in Austell ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology